P63, CK7, PAX8 and INI-1: An optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system

Histopathology

Volumn 60, Issue 4, 2012, Pages 597-608

  Carvalho, Jason C ^a   Thomas, Dafydd G ^a   Mchugh, Jonathan B ^a   Shah, Rajal B ^b   Kunju, Lakshmi P ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b CARIS LIFE SCIENCES   (United States)

Author keywords

Collecting duct carcinoma; Immunohistochemistry; P63; PAX8; Renal medullary carcinoma; Urothelial carcinoma

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CALCIUM BINDING PROTEIN; CARBONATE DEHYDRATASE IX; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; CYTOKERATIN 7; HIGH MOLECULAR WEIGHT CYTOKERATIN; HIGH MOLECULAR WEIGHT KININOGEN; INTEGRASE; INTEGRASE INTERACTOR 1; PROTEIN P63; S100A1 PROTEIN; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CANCER GRADING; CLEAR CELL RENAL CELL CARCINOMA; CLUSTER ANALYSIS; COLLECTING DUCT CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; MEDULLARY CARCINOMA; MOLECULAR WEIGHT; PAPILLARY RENAL CELL CARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL MEDULLARY CARCINOMA; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, RENAL CELL; CHROMOSOMAL PROTEINS, NON-HISTONE; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; HUMANS; KERATIN-7; KIDNEY NEOPLASMS; PAIRED BOX TRANSCRIPTION FACTORS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UROTHELIUM;

EID: 84863409904     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04093.x     Document Type: Article

References (22)

1. Eble JNSG, Epstein JI, Sesterhenn IA eds. World Health Organization classification of tumours. Lyon: IARC Press, 2004.
2. Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J. Urol. 2006; 176; 40-43; discussion 43.
3. Shah RB, Bakshi N, Hafez KS, Wood D Jr, Kunju LP. Image-guided biopsy in the evaluation of renal mass lesions in contemporary urological practice: indications, adequacy, clinical impact, and limitations of the pathological diagnosis. Hum. Pathol. 2005; 36; 1309-1315.
4. Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin. Diagn. Pathol. 1998; 15; 54-67.
5. Carvalho JC, Wasco MJ, Kunju LP, Thomas DG, Shah RB. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics. Histopathology 2011; 58; 169-179.
6. Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN, Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res. 2007; 27; 3051-3058.
7. Rocca PC, Brunelli M, Gobbo S et al. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Mod. Pathol. 2007; 20; 722-728.
8. Molinie V, Balaton A, Rotman S et al. Alpha-methyl CoA racemase expression in renal cell carcinomas. Hum. Pathol. 2006; 37; 698-703.
9. Tretiakova MS, Sahoo S, Takahashi M et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am. J. Surg. Pathol. 2004; 28; 69-76.
10. Kobayashi N, Matsuzaki O, Shirai S, Aoki I, Yao M, Nagashima Y. Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis. Hum. Pathol. 2008; 39; 1350-1359.
11. Gupta R, Balzer B, Picken M et al. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am. J. Surg. Pathol. 2009; 33; 241-247.
12. Tong GX, Yu WM, Beaubier NT et al. Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod. Pathol. 2009; 22; 1218-1227.
13. Ozcan A, Zhai Q, Javed R et al. PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin. Arch. Pathol. Lab. Med. 2010; 134; 1121-1129.
14. Ozcan A, Shen SS, Hamilton C et al. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod. Pathol. 2011; 24; 751-764.
15. Knoepp SM, Kunju LP, Roh MH. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology. Diagn. Cytopathol. 2010, [Epub ahead of print].
16. Gupta R, Paner GP, Amin MB. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv. Anat. Pathol. 2008; 15; 127-139.
17. Kunju LP, Mehra R, Snyder M, Shah RB. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma. Am. J. Clin. Pathol. 2006; 125; 675-681.
18. Langner C, Ratschek M, Tsybrovskyy O, Schips L, Zigeuner R. P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J. Histochem. Cytochem. 2003; 51; 1097-1099.
19. Albadine R, Schultz L, Illei P et al. PAX8(+)/p63(-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am. J. Surg. Pathol. 2010; 34; 965-969.
20. Cheng JX, Tretiakova M, Gong C, Mandal S, Krausz T, Taxy JB. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod. Pathol. 2008; 21; 647-652.
21. Elwood H, Schultz L, Illei PB et al. Immunohistochemical loss of INI-1expression in collecting duct carcinoma. Mod. Pathol. 2010; 23; 189A.
22. Albadine R, Schultz L, Billis A et al. PAX8(+)/p63(+) immunostaining pattern in renal medullary carcinoma: an intermediate phenotype between urothelial acrcinoma of upper urinary tract and collecting duct carcinoma. Mod. Pathol. 2010; 23; 174A.